FDA Orders Zantac, Similar Heartburn Medicines Off the Market

  • 📰 WSJ
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

The FDA ordered that the popular heartburn drug Zantac and other ranitidine generics be pulled from the market immediately, saying levels of a possible cancer-causing chemical found last year in some ranitidine products increases over time

U.S. health regulators ordered that the popular heartburn drug Zantac and other ranitidine generics be pulled from the market immediately, citing a potential public-health risk.

The Food and Drug Administration had found elevated levels of a possible cancer-causing chemical that led to voluntary recalls starting last year, including by French health-care giant Sanofi SA.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Try homeopathic medicines no risk no side effects

Nonsense

Out here it was taken off the shelves 5 months ago.

Oh this is lovely!!! I took Zantac for years!

I was taking it constantly when I got heartburn 😕😖

Omg.

**Of all COVID-19 deaths in NY, What % were treated with Hydrochloroquine plus Azithromycin: Early Onset TX: 0% Progressively Worse: 0% Death Bed: % I want to know how many people did NOT have to die. *** There is NO DOUBT this drug combo KILLS nCoV19 in 5 days.

darshanvmehta1 pls adv what are the contributions on these products to topline ... any impact on India operations !!

Bullshit....FDA wants to sell newer drugs at high price....US FDA hates Americans.

Dang ive taken these smh

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA orders all Zantac heartburn products off store shelvesAll Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, FDA says. Why tho F—- my life! I rely on this stuff to keep my heartburn at bay. I didn't use Zantac often, but I went back to Tums.
Source: NBCNews - 🏆 10. / 86 Read more »

The FDA Pulls Heartburn Drug Zantac From Stores Amid Carcinogen ConcernsThe carcinogen NDMA was found in ranitidine (Zantac), with levels increasing dangerously over time and in high storage temperatures.
Source: POPSUGAR Fitness - 🏆 401. / 53 Read more »

FDA Says Zantac Should Be Pulled From Market, Citing Cancer RiskMajor pharmacies had already pulled the popular heartburn drug and its generic equivalents due to a contaminant. Now the Food and Drug Administration says definitively they should not be sold or used. Oh, now EVIL $ FDA $ WANTS TO PULL POISON ZANTAC, MILLIONS HAVE CANCER NOW$$$$$$$$$$$$$$$$$ They did that last year. Have you or a loved one taken medication like Zantac, and experienced abdominal pain or stomach or other cancers? You could be entitled to compensation. Call Utah's Robert DeBry and Associates right now at 801-699-9999 or online at zantac zantacrecall
Source: NPR - 🏆 96. / 63 Read more »

The Biggest Non-Coronavirus Stories You Missed Today: Trump Says Iran Is Planning A ‘Sneak Attack,’ FDA Pulls Heartburn Drug ZantacI’m a San Francisco-based reporter covering breaking news at Forbes. Previously, I’ve reported for USA Today, Business Insider, The San Francisco Business Times and San Jose Inside. I studied journalism at Syracuse University’s S.I. Newhouse School of Public Communications and was an editor at The Daily Orange, the university’s independent student newspaper. Follow me on Twitter rachsandl or shoot me an email rsandlerforbes.com. Frying Wells Fargo? Best news I’ve seen today.
Source: Forbes - 🏆 394. / 53 Read more »

The Biggest Non-Coronavirus Stories You Missed Today: Trump Says Iran Is Planning A ‘Sneak Attack,’ FDA Pulls Heartburn Drug ZantacI’m a San Francisco-based reporter covering breaking news at Forbes. Previously, I’ve reported for USA Today, Business Insider, The San Francisco Business Times and San Jose Inside. I studied journalism at Syracuse University’s S.I. Newhouse School of Public Communications and was an editor at The Daily Orange, the university’s independent student newspaper. Follow me on Twitter rachsandl or shoot me an email rsandlerforbes.com.
Source: Forbes - 🏆 394. / 53 Read more »